| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA622574 | ADME | Pharmacokinetic parameter AUC after intravenous administration to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 2. | ALA622575 | ADME | Pharmacokinetic parameter AUC after oral administration to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 3. | ALA623285 | ADME | Bioavailability administered orally at a dose of 10 mg/kg to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 4. | ALA624456 | ADME | Plasma administration to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 5. | ALA627879 | ADME | Maximum plasma concentration after oral administration to dogs at a dose of 10 mg/kg | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 6. | ALA623680 | ADME | Time to reach Cmax after oral administration to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 7. | ALA618722 | ADME | Steady state volume of distribution was determined | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 8. | ALA624298 | ADME | Half life was evaluated after intravenous administration to dogs | Canis lupus familiaris | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 9. | ALA622981 | ADME | Plasma administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 10. | ALA624286 | ADME | Time to reach Cmax after oral administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 11. | ALA620531 | ADME | Steady state volume of distribution was determined | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 12. | ALA623990 | ADME | Maximum plasma concentration after oral administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 13. | ALA873820 | ADME | Half life was evaluated after intravenous administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 14. | ALA625909 | ADME | Pharmacokinetic parameter AUC after intravenous administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 15. | ALA625910 | ADME | Pharmacokinetic parameter AUC after oral administration to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 16. | ALA626749 | ADME | Bioavailability administered orally at a dose of 10 mg/kg to rats | Rattus norvegicus | 1 | ALA1134398 | organism-based format | Scientific Literature | |
| 17. | ALA649541 | Binding | Inhibitory activity against human angiotensin I converting enzyme (10 uM); No inhibition | 1 | ALA1134398 | single protein format | Scientific Literature | ||
| 18. | ALA660458 | Binding | In vitro inhibitory activity was determined against bovine pancreas chymotrypsin | 29 | ALA1134398 | single protein format | Scientific Literature | ||
| 19. | ALA678449 | Binding | Inhibitory activity against human leukocyte elastase (10 uM); No inhibition | 1 | ALA1134398 | single protein format | Scientific Literature | ||
| 20. | ALA820311 | Binding | Inhibitory activity against human cathepsin G | 1 | ALA1134398 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!